tiprankstipranks
MeVis Medical Solutions AG (GB:0HI7)
LSE:0HI7

MeVis Medical Solutions (0HI7) Share Price & Analysis

0 Followers

0HI7 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€31.20 - €31.20
Previous Close€31.2
Volume0.00
Average Volume (3M)N/A
Market Cap
€48.41M
Enterprise Value€39.09M
Total Cash (Recent Filing)€9.32M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)11.5
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.70
Shares Outstanding1,820,000
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.05
R-Squared0.01
Alpha0.00853
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

0HI7 FAQ

What was MeVis Medical Solutions AG’s price range in the past 12 months?
MeVis Medical Solutions AG lowest share price was €31.20 and its highest was €31.20 in the past 12 months.
    What is MeVis Medical Solutions AG’s market cap?
    Currently, no data Available
    When is MeVis Medical Solutions AG’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were MeVis Medical Solutions AG’s earnings last quarter?
    Currently, no data Available
    Is MeVis Medical Solutions AG overvalued?
    According to Wall Street analysts MeVis Medical Solutions AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does MeVis Medical Solutions AG pay dividends?
      MeVis Medical Solutions AG pays a Annually dividend of €0.95 which represents an annual dividend yield of N/A. See more information on MeVis Medical Solutions AG dividends here
        What is MeVis Medical Solutions AG’s EPS estimate?
        MeVis Medical Solutions AG’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does MeVis Medical Solutions AG have?
        MeVis Medical Solutions AG has 1,820,000 shares outstanding.
          What happened to MeVis Medical Solutions AG’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of MeVis Medical Solutions AG?
          Currently, no hedge funds are holding shares in GB:0HI7
          ---

          MeVis Medical Solutions Stock Smart Score

          7
          Neutral
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Positive
          20 days / 200 days
          Momentum
          0.00%
          12-Months-Change

          Fundamentals

          Return on Equity
          27.60%
          Trailing 12-Months
          Asset Growth
          -10.09%
          Trailing 12-Months

          Company Description

          MeVis Medical Solutions AG

          MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          DocCheck AG
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis